367 related articles for article (PubMed ID: 8632412)
1. Structure-activity relationships among 2-substituted 5,6-dichloro-, 4,6-dichloro-, and 4,5-dichloro-1-[(2-hydroxyethoxy) methyl]- and -1-[(1,3-dihydroxy-2-propoxy) methyl]benzimidazoles.
Saluja S; Zou R; Drach JC; Townsend LB
J Med Chem; 1996 Feb; 39(4):881-91. PubMed ID: 8632412
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and antiviral evaluation of 2-substituted 4,5-dichloro- and 4,6-dichloro-1-beta-D-ribofuranosylbenzimidazoles as potential agents for human cytomegalovirus infections.
Zou R; Drach JC; Townsend LB
J Med Chem; 1997 Feb; 40(5):802-10. PubMed ID: 9057867
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and antiviral activity of alpha-nucleosides: D- and L-isomers of lyxofuranosyl- and (5-deoxylyxofuranosyl)benzimidazoles.
Migawa MT; Girardet JL; Walker JA; Koszalka GW; Chamberlain SD; Drach JC; Townsend LB
J Med Chem; 1998 Apr; 41(8):1242-51. PubMed ID: 9575044
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and ++thiosangivamycin: influence of various 7-substituents on antiviral activity.
Renau TE; Wotring LL; Drach JC; Townsend LB
J Med Chem; 1996 Feb; 39(4):873-80. PubMed ID: 8632411
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and antiviral evaluation of 2-deoxy-D-ribosides of substituted benzimidazoles as potential agents for human cytomegalovirus infections.
Zou R; Kawashima E; Freeman GA; Koszalka GW; Drach JC; Townsend LB
Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):125-53. PubMed ID: 10772706
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antiproliferative and antiviral activity of carbohydrate-modified pyrrolo[2,3-d]pyridazin-7-one nucleosides.
Meade EA; Wotring LL; Drach JC; Townsend LB
J Med Chem; 1997 Feb; 40(5):794-801. PubMed ID: 9057866
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and antiviral evaluations of 1-(substituted benzyl)-2-substituted-5,6-dichlorobenzimidazoles as nonnucleoside analogues of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole.
Porcari AR; Devivar RV; Kucera LS; Drach JC; Townsend LB
J Med Chem; 1998 Apr; 41(8):1252-62. PubMed ID: 9548815
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and antiviral evaluation of 2-chloro-5,6-dihalo-1-beta-D-ribofuranosylbenzimidazoles as potential agents for human cytomegalovirus infections.
Zou R; Drach JC; Townsend LB
J Med Chem; 1997 Feb; 40(5):811-8. PubMed ID: 9057868
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antiviral evaluation of certain disubstituted benzimidazole ribonucleosides.
Zou R; Ayres KR; Drach JC; Townsend LB
J Med Chem; 1996 Aug; 39(18):3477-82. PubMed ID: 8784445
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antiviral activity of certain 5'-modified analogs of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole.
Gudmundsson KS; Drach JC; Wotring LL; Townsend LB
J Med Chem; 1997 Feb; 40(5):785-93. PubMed ID: 9057865
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antiviral evaluation of polyhalogenated imidazole nucleosides: dimensional analogues of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole.
Chien TC; Saluja SS; Drach JC; Townsend LB
J Med Chem; 2004 Nov; 47(23):5743-52. PubMed ID: 15509173
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antiviral evaluation of halogenated beta-D- and -L-erythrofuranosylbenzimidazoles.
Gudmundsson KS; Tidwell J; Lippa N; Koszalka GW; van Draanen N; Ptak RG; Drach JC; Townsend LB
J Med Chem; 2000 Jun; 43(12):2464-72. PubMed ID: 10882374
[TBL] [Abstract][Full Text] [Related]
13. Benzimidazole 2'-isonucleosides: design, synthesis, and antiviral activity of 2-substituted-5,6-dichlorobenzimidazole 2'-isonucleosides.
Freeman GA; Selleseth DW; Rideout JL; Harvey RJ
Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):155-74. PubMed ID: 10772707
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, antiproliferative, and antiviral activity of certain 4-substituted and 4,5-disubstituted 7-[(1,3-dihydroxy-2-propoxy)methyl]pyrrolo[2,3-d]pyrimidines.
Pudlo JS; Nassiri MR; Kern ER; Wotring LL; Drach JC; Townsend LB
J Med Chem; 1990 Jul; 33(7):1984-92. PubMed ID: 2163454
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antiviral activity of certain 4-substituted and 2,4-disubstituted 7-[(2-hydroxyethoxy)methyl]pyrrolo[2,3-d]pyrimidines.
Saxena NK; Hagenow BM; Genzlinger G; Turk SR; Drach JC; Townsend LB
J Med Chem; 1988 Aug; 31(8):1501-6. PubMed ID: 2840500
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of acyclic nucleoside analogs with chlorinated imidazo[1,2-a]pyridine bases.
Williams JD; Mourad AE; Drach JC; Townsend LB
Nucleosides Nucleotides Nucleic Acids; 2003 Oct; 22(10):1907-17. PubMed ID: 14609230
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, cytotoxicity, and antiviral activity of some acyclic analogues of the pyrrolo[2,3-d]pyrimidine nucleoside antibiotics tubercidin, toyocamycin, and sangivamycin.
Gupta PK; Daunert S; Nassiri MR; Wotring LL; Drach JC; Townsend LB
J Med Chem; 1989 Feb; 32(2):402-8. PubMed ID: 2913300
[TBL] [Abstract][Full Text] [Related]
18. Convergent synthesis of polyhalogenated quinoline C-nucleosides as potential antiviral agents.
Chen JJ; Drach JC; Townsend LB
J Org Chem; 2003 May; 68(11):4170-8. PubMed ID: 12762715
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of fluorosugar analogues of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole as antivirals with potentially increased glycosidic bond stability.
Gudmundsson KS; Freeman GA; Drach JC; Townsend LB
J Med Chem; 2000 Jun; 43(12):2473-8. PubMed ID: 10882375
[TBL] [Abstract][Full Text] [Related]
20. Syntheses of 1-[(2-hydroxyethoxy)methyl]- and 1-[(1,3-dihydroxy-2-propoxy)methyl]- derivatives of 5-substituted-2,4-difluorobenzene: unnatural acyclo thymidine mimics for evaluation as anticancer and antiviral agents.
Wang ZX; Duan W; Wiebe LI; De Clercq E; Balzarini J; Knaus EE
Nucleosides Nucleotides Nucleic Acids; 2000 Sep; 19(9):1397-411. PubMed ID: 11092311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]